IBRUTINIB IN MONOTHERAPY AS A TREATMENT OF RELAPSED MANTLE CELL LYMPHOMA IN THE CENTRAL NERVOUS SYSTEM. CASE REPORT

被引：0
|
作者：
Morales de la Plaza, A. [1 ]
Santero Garcia, M. [1 ]
Sebrango Sadia, A. [1 ]
机构：
[1] Hosp Univ Torrejon, Madrid, Spain
来源：
HAEMATOLOGICA | 2018年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-060
引用
收藏
页码：337 / 337
页数：1
相关论文
共 50 条
  • [21] Central nervous system involvement in mantle cell lymphoma
    Ferrer, A.
    Bosch, F.
    Villamor, N.
    Rozman, M.
    Graus, F.
    Gutierrez, G.
    Mercadal, S.
    Campo, E.
    Rozman, C.
    Lopez-Guillermo, A.
    Montserrat, E.
    ANNALS OF ONCOLOGY, 2008, 19 (01) : 135 - 141
  • [22] Central Nervous System Involvement By Mantle Cell Lymphoma
    McLaughlin, Nicole
    Paludo, Jonas
    Wang, Yucai
    Inwards, David J.
    Bennani, Nora
    Thanarajasingam, Gita
    Villasboas, Jose C.
    Nowakowski, Grzegorz S.
    Porrata, Luis F.
    Thompson, Carrie A.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Witzig, Thomas E.
    Habermann, Thomas M.
    Ansell, Stephen M.
    BLOOD, 2021, 138
  • [23] Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib - Case report
    Barrett, Aisling
    Eyre, Toby A.
    Bhuva, Shaheel
    Aljurf, Mahmoud
    El Fakih, Riad
    Ashshi, Mohammad A.
    Alshaibani, Alfadel
    EJHAEM, 2024, 5 (01): : 238 - 241
  • [24] Rare case of ocular adnexal relapse with mantle cell lymphoma treated with ibrutinib monotherapy
    Nishiyama-Fujita, Yuriko
    Nakazato, Tomonori
    Ito, Chisako
    Ogura, Shinji
    Mizuno, Kota
    Kamiya, Takahiro
    Aisa, Yoshinobu
    Mori, Takehiko
    INTERNAL MEDICINE JOURNAL, 2019, 49 (09) : 1187 - 1189
  • [25] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
  • [26] Primary Lymphoma of the Central Nervous System. Case Presentation
    Fernandez Aguila, Julio Damaso
    Valladares Urquiza, Yanisleidys
    Rodriguez Pino, Martha Yudey
    Alvarez, Icilany Villares
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2018, 16 (02): : 344 - 351
  • [27] A phase II study of obinutuzumab in combination with ibrutinib for treatment of relapsed mantle cell lymphoma
    Kim, Myung Sun
    Banerjee, Titas
    Chen, Andy
    Danilov, Alexey
    MacKinnon, Renee
    Thurlow, Bria
    Thakurta, Sujata
    Orand, Kirsten
    Degnin, Catherine
    Park, Byung
    Spurgeon, Stephen E.
    LEUKEMIA & LYMPHOMA, 2023, 64 (03) : 722 - 724
  • [28] Ibrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma in Community Clinical Practice Outside of Clinical Trials
    Vorobyev, Vladimir I.
    Zherebtsova, Vera A.
    Dubrovin, Egor I.
    Bychenkova, Liudmila A.
    Butaev, Lev S.
    Muha, Larisa A.
    Kochkareva, Yulia B.
    Ivanova, Valentina L.
    Nikitin, Eugene A.
    Tumyan, Gayane
    Doronin, Vadim A.
    Krijanovski, Oleg I.
    Ptushkin, Vadim
    BLOOD, 2019, 134
  • [29] Ibrutinib as monotherapy versus combination therapy in Chinese patients with relapsed/refractory mantle cell lymphoma: A multicenter study
    Zhang, Yuchen
    Liu, Panpan
    Cai, Jun
    Jing, Hongmei
    Zou, Liqun
    Huang, Huiqiang
    Wu, Yuanbin
    Li, Wenyu
    Zhong, Liye
    Jin, Xueli
    Ye, Xu
    Feng, Ru
    Zhang, Huilai
    Zhang, Liling
    Lin, Lie
    Sun, Xiuhua
    Tian, Yuyang
    Xia, Zhongjun
    Li, Zhiming
    Huang, He
    Xia, Yi
    Cai, Qingqing
    CANCER MEDICINE, 2022, 11 (22): : 4134 - 4145
  • [30] COMPLETE REMISSION INDUCED BY FOTEMUSTINE AS SALVAGE TREATMENT IN RELAPSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: A CASE REPORT
    Pennese, E.
    De Paolis, M. R.
    Forese, P.
    Vergine, C.
    Di Renzo, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 636 - 636
12345